<DOC>
	<DOCNO>NCT01228604</DOCNO>
	<brief_summary>This study open-label , 6 month trial , immediate release methylphenidate ( MPH-IR ) child ADHD aim assess whether observable behavioral change see treatment associate potentially stable underlying modification brain functioning ( resting-state functional connectivity ) . Additionally , also look treatment effect neuropsychological process read skill . This information contribute first Brazilian study assess cost-effectiveness treatment ADHD . Children ADHD compare sample sex age-matched sample typically develop child .</brief_summary>
	<brief_title>Cost-Effectiveness Study Of The Treatment Of Attention Deficit/Hyperactivity Disorder In Brazil</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>The study include 20 boy age 8 10 year old , regularly enrol local school direct research advertisement medium , contact school directly refer Attention Deficit/Hyperactivity Program ( ProDAH/HCPA ) primary care service assessment treatment . Only child primary diagnosis ADHD comorbidity ADHD + read disorder ADHD + ODD include . Only drugnaïve subject apt participate study . Children fit one follow condition consider eligible take part study : ( 1 ) outside age range specify ; ( 2 ) regularly enrol attending school ; ( 3 ) history prior current treatment psychoactive drug psychotherapy ; ( 4 ) mentally retarded ( Overall IQ &lt; 80 ) ; ( 5 ) main diagnosis differ ADHD , include child psychiatric neurological diagnosis</criteria>
	<gender>Male</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>open label</keyword>
	<keyword>Ritalin®</keyword>
	<keyword>ADHD</keyword>
</DOC>